Navigation Links
Cmed Technology to Preview New Innovations to Speed and Streamline Electronic Trials at DIA Conference

NEW PROVIDENCE, N.J., June 8, 2011 /PRNewswire/ -- Cmed Technology, an innovative provider of eClinical technology, announced today it will preview its forthcoming Timaeus Guided Trial Builder product at this month's Drug Information Association (DIA) Annual Meeting in Chicago, IL. Guided Trial Builder will introduce an entirely different approach to simplify and streamline the startup of electronic trials. It expands on the Timaeus on-demand eClinical platform's history of harnessing innovation to empower clinical research teams to do more—in more places—with less time and effort.


Guided Trial Builder will enable non-programmers to rapidly build entire trials, including visit schedules, pages and edit checks. It automatically ensures adherence to standards and seamlessly validates the trial during the build process, eliminating the need for manual quality control (QC) and hand-off between teams. Adding Guided Trial Builder to Timaeus' on-demand deployment capabilities allows study teams to start new trials and perform mid-trial updates at the touch of a button—without downtime or site interruption. Cmed Technology is currently working with a Top 10 pharmaceutical company to quantify the time and efficiency improvements Guided Trial Builder will provide.

"Today, more than ever, speed is everything as pharmaceutical and biotech companies look for faster trial builds, earlier go-live dates and immediate access to clinical trial data," said Dr. David Connelly, CEO of Cmed. "Guided Trial Builder expands on our many years of work building eClinical technology that can rapidly respond to the needs of research organizations. Imagine the benefits of building and deploying entire study databases in days—rather than weeks or months."

Cmed Technology will highlight how Timaeus 5 benefits various clinical trial roles at its DIA Booth 1662. Visitors will be able to build, immediately deploy and conduct user acceptance testing (UAT) on trials themselves. They will be able to capture data, perform source data verification (SDV) and run real-time reports using Timaeus Web. They also can explore a fast, reliable and secure mobile experience using the Apple iPad® with Timaeus HotSpot, the industry's first portable eClinical suite. To schedule a demonstration, please send an email to or register online at

About Cmed Technology

Cmed Technology is an innovative provider of eClinical technology and solutions. Its unified eClinical platform, Timaeus, combines advanced distributed cloud, mobile and tablet computing technologies to provide research organizations the freedom to manage any type of data, for any trial, anywhere. Created in 2002, Timaeus has been used by biopharmaceutical companies, non-profit institutions, CROs and other research organizations for early phase, pivotal and late phase studies. Timaeus provides on-demand solutions for programming of simple, complex and adaptive trials (Timaeus Trial Builder); electronic data capture (Timaeus Electronic Data Capture); monitoring (Timaeus Field Monitoring); in-stream coding (Timaeus Medical Coding); electronic, paper, and hybrid trial data management (Timaeus Electronic Data Management); and clinical and operational reporting (Timaeus Reporting). A division of the Cmed Group with roots from the University of Oxford, Cmed Technology has offices in the United Kingdom, the United States and Romania. To learn more, visit

Media Contacts:
Cmed Technology
Christopher Leary or +1 908-795-2006

Randy Wambold or +1 781-672-3119

SOURCE Cmed Technology
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. VG Energys Lipid Enhancement Technology Independently Confirmed in First Phase of Testing for Potential Commercial Production of Biofuels
2. Reportlinker Adds Future of White Biotechnology in China
3. Asmacure Ltee Appoints Pharmaceutical and Biotechnology Industry Veteran Martin Driscoll as CEO
4. C3i Inc to Provide Full-Service Technology Support and Oracle Clinical, Oracle Remote Data Capture Business Process Outsourcing to XBiotech, Inc
5. New technology could inspire brain implant for detecting and treating seizures
6. Science & Technology News Service Expands Coverage
7. From seawater to freshwater with a nanotechnology filter
8. Enox Biopharma, Inc. Expands Its Technology to Cover the Wound Care Market
9. DNA Technology on the Menu in 11,000 U.S. Restaurants
10. Reportlinker Adds Technology Transfer Strategies - A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical Industries
11. Lixte Biotechnology Holdings Announces New Appointment to Board of Directors
Post Your Comments:
(Date:11/26/2015)... MUMBAI , November 26, 2015 ... --> Accutest Research ... accredited Contract Research Organization (CRO), has ... Chase Cancer Center - Temple Health ... ,     (Photo: ) ...
(Date:11/25/2015)... BRUSSELS , November 25, 2015 ... in cat and human plaque and pave the way for ... health problems in cats     ... the most commonly diagnosed health problems in cats, yet relatively ... until now. Two collaborative studies have been conducted by researchers ...
(Date:11/25/2015)... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) ... chat discussion at the Piper Jaffray 27th Annual Healthcare ... discussion is scheduled for Wednesday, December 2, at 8:00 ... replay will be available for 14 days after the ... NormartVP, Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
(Date:11/24/2015)... Calif. , Nov. 24, 2015 Cepheid ... will be speaking at the following conference, and invited ... New York, NY      Tuesday, December 1, 2015 ... New York, NY      Tuesday, December 1, 2015 ... Jaffray Healthcare Conference, New York, NY ...
Breaking Biology Technology:
(Date:11/20/2015)... , November 20, 2015 ... company focused on the growing mobile commerce market and ... Gino Pereira , was recently interviewed on ... will air on this weekend on Bloomberg Europe ... America . --> NXTD ) ("NXT-ID" or ...
(Date:11/18/2015)... --> --> ... report titled  Gesture Recognition Market - Global Industry Analysis, ... to the report, the global gesture recognition market was valued at ... US$29.1 bn by 2021, at a CAGR of 20.3% ... dominated the global gesture recognition market in ...
(Date:11/17/2015)... 17, 2015 Pressure BioSciences, Inc. (OTCQB: PBIO) ... and sale of broadly enabling, pressure cycling technology ("PCT")-based ... today announced it has received gross proceeds of $745,000 ... Placement (the "Offering"), increasing the total amount raised to ... additional closings are expected in the near future. ...
Breaking Biology News(10 mins):